Olprinone

CAS No. 106730-54-5

Olprinone ( Loprinone )

Catalog No. M19774 CAS No. 106730-54-5

Olprinone(Loprinone) is a selective phosphodiesterase 3 (PDE3) inhibitor.Olprinone has been reported to improve microcirculation and attenuate inflammation. Olprinone is often used to increase cardiac output after cardiopulmonary bypass (CPB).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 In Stock
5MG 70 In Stock
10MG 102 In Stock
25MG 169 In Stock
50MG 255 In Stock
100MG 377 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Olprinone
  • Note
    Research use only not for human use.
  • Brief Description
    Olprinone(Loprinone) is a selective phosphodiesterase 3 (PDE3) inhibitor.Olprinone has been reported to improve microcirculation and attenuate inflammation. Olprinone is often used to increase cardiac output after cardiopulmonary bypass (CPB).
  • Description
    Olprinone(Loprinone) is a selective phosphodiesterase 3 (PDE3) inhibitor.Olprinone has been reported to improve microcirculation and attenuate inflammation. Olprinone is often used to increase cardiac output after cardiopulmonary bypass (CPB).
  • Synonyms
    Loprinone
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE3
  • Research Area
    Metabolic Disease
  • Indication
    Heart failure

Chemical Information

  • CAS Number
    106730-54-5
  • Formula Weight
    250.26
  • Molecular Formula
    C14H10N4O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10mM
  • SMILES
    Cc1[nH]c(=O)c(cc1-c1ccc2nccn2c1)C#N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tsubokawa T Ishizuka S Fukumoto K et al. The effect of hemodilution by cardiopulmonary bypass on protein binding of olprinone. J Anesth. 2012 .
molnova catalog
related products
  • Mirodenafil

    Mirodenafil is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.The pharmacoki-netics of mirodenafil were not significantly altered by this concurrent administration. Mirodenafil (50 or 100 mg), obviously improved erectile function and was well tolerated in a representative population of Korean men with broad-spectrum ED of various etiologies and severities.

  • Enoximone

    Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.

  • PF-03049423

    PF-03049423 is a potent, selective, orally active, and brain penetrant inhibitor of PDE5 with IC50 of 0.2 nM.